BioPartnering North America is North-America’s 2nd largest conference devoted to biotechnology. The 2012 edition brought together over 680 delegates from 422 companies and 28 countries. 2026 meetings were scheduled.
For the fourth year in a row, The French Trade Commission in Canada brought a delegation of biotech companies from France.
15 French delegates attended the event making France the most important European delegation.
During the three days of the conference, the 15 delegate companies made the most of the B2B meetings and networking events to develop and increase their international business relations. The receptions offered by the organizer TVG were great networking opportunities for all the delegates, in prestigious locations such as the Vancouver Aquarium.
On the morning of February 29th, the French delegates had the opportunity to visit local research centres: Discovery Park ( to meet with biotech companies), Centre for Drug Research & Development, Ubc Centre for Comparative Medicine, Prostate Centre, Genome Sciences Centre…
In addition to the B2B meetings, the “Ubifrance Canada” booth generated traffic, potential business and increased the visibility of the French delegation.
A great 2012 edition which will certainly lead to a 5th participation of UBifrance at BPN 2013.
For the fourth year in a row, The French Trade Commission UBifrance Canada is partnering with BPN, North-America’s 2nd largest conference devoted to biotechnology. In 2011 France was represented by no less than 12 individual firms and 3 clusters, making France the third most important national delegation after Canada and the United States.
The French Trade Commission is delighted to present a unique trade mission to create and stimulate partnering opportunities for French and Canadian companies in the biotechnology market and to introduce French expertise. All participants are willing to establish or increase their international business relations and to develop closer contacts with both the global Canadian market and local western companies.
French companies will be in Vancouver from February 26th to 29th to present themselves and share their experience during the three days of the conference.
Don’t miss this unique network opportunity to meet directly 15 French major biotech players at BPN on an international scope. Our delegation is composed by the following companies :
•Affilogic - www.affilogic.com
•Alsace Biovalley - www.alsace-biovalley.com
•Ariana Pharmaceuticals – www.arianapharma.com
•Bioalternatives – www.bioalternatives.com
•Cohiro – www.cohiro.fr
•Eurasanté – www.eurasante.com
•Novalix – www.novalix-pharma.com
•Invest in Western France – www.western-france.eu
•Physiostim – www.physiostim.com
•Plant Advanced Technologies – www.plantadvanced.com
•Prestwick Chemical – www.prestwickchemical.com
•PX’Therapeutics – www.px-therapeutics.com
•Roowin – www.roowin.com
•Vivalis – www.vivalis.com
BioPartnering North America is North-America’s 2nd largest conference devoted to biotechnology. The 2011 edition brought together over 800 delegates from 500 companies and 28 countries. 2,500 meetings were scheduled.
For the third year in a row, The French Trade Commission in Canada brought a delegation of biotech companies from France. 15 French delegates attended the event making France the most important European delegation.